LUM and cancer: Elevated LUM levels were correlated with increased sensitivity of cancer cell lines to (5Z)-7-Oxozeaenol, 17-AAG, docetaxel, GSK269962A, midostaurin, pazopanib, RDEA119, as well as SB216763 and decreased activities of 5-Fluorouracil, AICAR, AT-751g, CUDC-101, EKU-569, GSK690693, I-BET-762, ispinesib mesylate, KIN001-102, LAQ824, methotrexate, NPK76-II-72-1, navitoclax, PHA-793887, PIK-93, SNX-2112, TAK-715, THZ-2-102-1, TPCA-1, tubastain A, WZ3105, and ZSTK474 in various cancer cell lines (Figure 7A).